NO922530L - Cykliske imid-derivater - Google Patents

Cykliske imid-derivater

Info

Publication number
NO922530L
NO922530L NO92922530A NO922530A NO922530L NO 922530 L NO922530 L NO 922530L NO 92922530 A NO92922530 A NO 92922530A NO 922530 A NO922530 A NO 922530A NO 922530 L NO922530 L NO 922530L
Authority
NO
Norway
Prior art keywords
cyclic imid
derivatives
imid derivatives
cyclic
imid
Prior art date
Application number
NO92922530A
Other languages
English (en)
Norwegian (no)
Other versions
NO922530D0 (no
Inventor
Peter Leslie Myers
Andrew Brian Mcelroy
Michael Gregson
Peter Jonathan Brown
Howard Geoffrey Davies
David Harold Drewry
Michael Andrew Foley
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919113844A external-priority patent/GB9113844D0/en
Priority claimed from GB919113930A external-priority patent/GB9113930D0/en
Priority claimed from GB929209402A external-priority patent/GB9209402D0/en
Priority claimed from GB929210343A external-priority patent/GB9210343D0/en
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of NO922530D0 publication Critical patent/NO922530D0/no
Publication of NO922530L publication Critical patent/NO922530L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO92922530A 1991-06-27 1992-06-26 Cykliske imid-derivater NO922530L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919113844A GB9113844D0 (en) 1991-06-27 1991-06-27 Chemical compounds
GB919113930A GB9113930D0 (en) 1991-06-27 1991-06-27 Chemical compounds
GB929209402A GB9209402D0 (en) 1992-04-30 1992-04-30 Chemical compounds
GB929210343A GB9210343D0 (en) 1992-05-14 1992-05-14 Chemical compounds

Publications (2)

Publication Number Publication Date
NO922530D0 NO922530D0 (no) 1992-06-26
NO922530L true NO922530L (no) 1992-12-28

Family

ID=27450705

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922530A NO922530L (no) 1991-06-27 1992-06-26 Cykliske imid-derivater

Country Status (10)

Country Link
US (1) US5252560A (fr)
EP (1) EP0520573A1 (fr)
JP (1) JPH0625284A (fr)
KR (1) KR930000481A (fr)
AU (1) AU1864092A (fr)
CA (1) CA2072551A1 (fr)
FI (1) FI922964A7 (fr)
IE (1) IE922083A1 (fr)
MX (1) MX9203643A (fr)
NO (1) NO922530L (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530161A (en) * 1991-07-08 1996-06-25 British Bio-Technology Limited Hydroxamic acid based collagenase inhibitors
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties
AUPM627594A0 (en) * 1994-06-16 1994-07-07 Willis, Gregory Lynn Dr Animal bedding material
WO1996033733A1 (fr) * 1995-04-25 1996-10-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Nouveau remede pour affections cutanees
GB9613547D0 (en) * 1996-06-27 1996-08-28 Pharmacia Spa Matrix metalloproteinase inhibitors
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
ES2274378T3 (es) 1999-08-10 2007-05-16 Glaxo Group Limited Ligando del receptor ep4 y uso contra dolor neuropatico, cancer de colon,hiv y migraña.
KR100840816B1 (ko) 2000-05-12 2008-06-23 젠자임 코포레이션 TNF-α시그널링의 조절물질
EP1469875A1 (fr) * 2002-01-29 2004-10-27 Wyeth Compositions et procedes de modulation des demi-canaux de connexines
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
PL1742642T3 (pl) * 2004-04-14 2009-06-30 Gilead Sciences Inc Analogi fosfonianowe związków inhibitorów integrazy HIV
SI3102576T1 (sl) 2014-02-03 2019-08-30 Vitae Pharmaceuticals, Llc Inhibitorji dihidropirolopiridina ROR-gama
CN104130144A (zh) * 2014-07-30 2014-11-05 新疆农垦科学院 酞酸酯类塑化剂通用半抗原、抗原的合成方法及应用
BR112017007460A2 (pt) 2014-10-14 2017-12-19 Vitae Pharmaceuticals Inc inibidores de di-hidropirrolopiridina de ror-gama
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
ES2856931T3 (es) 2015-08-05 2021-09-28 Vitae Pharmaceuticals Llc Moduladores de ROR-gamma
WO2017087608A1 (fr) 2015-11-20 2017-05-26 Vitae Pharmaceuticals, Inc. Modulateurs de ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2019018975A1 (fr) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. Inhibiteurs de ror gamma
KR20200053481A (ko) 2017-07-24 2020-05-18 비타이 파마슈티컬즈, 엘엘씨 RORγ의 억제제
KR20230158005A (ko) 2021-03-18 2023-11-17 씨젠 인크. 생물학적 활성 화합물의 내재화된 접합체로부터의 선택적 약물 방출

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2025996A1 (de) * 1970-05-27 1971-12-09 Chemie Grünenthal GmbH, 5190 Stolberg Abkömmlinge von Mercaptocarbonsäuren
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
ZW23187A1 (en) * 1986-12-15 1988-06-29 Hoffmann La Roche Phosphinic acid derivatives
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
EP0369391A3 (fr) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. Amides N-substitués
EP0401963A1 (fr) * 1989-04-13 1990-12-12 Beecham Group p.l.c. Phosphonopeptides avec activité inhibitrice de collagénase
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
WO1991005555A2 (fr) * 1989-10-13 1991-05-02 The Salk Institute Biotechnology/Industrial Associates, Inc. Inhibiteurs de metalloendopeptidases peptidiques de n-acyle et leurs modes d'emploi
WO1991005763A1 (fr) * 1989-10-13 1991-05-02 The Salk Institute Biotechnology/Industrial Associates, Inc. Inhibiteurs de metalloendopeptidase a base d'analogues dipeptidiques et leurs modes d'emploi
WO1991008222A1 (fr) * 1989-11-24 1991-06-13 Banyu Pharmaceutical Co., Ltd. Substance physiologiquement active be-16627
GB9008078D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
EP1069137A1 (fr) * 1990-09-24 2001-01-17 W.R. Grace & Co.-Conn. Peptides ayant une activité de type thrombospondine et leur utilisation thérapeutique
ATE120182T1 (de) * 1990-12-03 1995-04-15 Celltech Ltd Peptidylderivate.

Also Published As

Publication number Publication date
KR930000481A (ko) 1993-01-15
AU1864092A (en) 1993-01-07
FI922964A7 (fi) 1992-12-28
NO922530D0 (no) 1992-06-26
JPH0625284A (ja) 1994-02-01
IE922083A1 (en) 1992-12-30
MX9203643A (es) 1995-01-31
CA2072551A1 (fr) 1992-12-28
FI922964A0 (fi) 1992-06-26
US5252560A (en) 1993-10-12
EP0520573A1 (fr) 1992-12-30

Similar Documents

Publication Publication Date Title
FI934223L (fi) Heterocykliscykliska aminderivat
NO922530D0 (no) Cykliske imid-derivater
DE69208877D1 (de) Chinuclidinderivate
FI924160A7 (fi) Benzanilidderivat
FI935726A7 (fi) Atsanorbornaanijohdannaisia
FI924159L (fi) Benzanilidderivat
NO922182D0 (no) Krystallinske oksatiolan-derivater
FI922481A7 (fi) Heterosyklisiä johdannaisia
DE59208415D1 (de) 3-Hydroxy-4-aryl-5-oxo-pyrazolin Derivate
FI921690L (fi) Heterosykliska amider
FI942766A7 (fi) 20-metyylisubstituoituja D-vitamiinijohdannaisia
FI941324L (fi) 10-desasetoksitaksolijohdannaisia
FI925422L (fi) Indolopyrrolokarbazolderivat
FI921262L (fi) 4-aryltiazol- eller 4-arylimidazolderivat
FI925763L (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI923726L (fi) Sulfaterade glykosaminoglykanoidderivat
FI942114L (fi) D-vitamiiniamidijohdannaiset
FI930345L (fi) Foerfarande foer framstaellning av renat akrylamidosulfonsyramonomerderivat
FI935243L (fi) Pyridonkarboxylsyraderivat
NO923581D0 (no) Sykliske substituerte imidazolylpropensyrederivater
DE69221652D1 (de) Substituiertes cyclisches Sulfamidderivat
FI920394A7 (fi) 3-kinuklidiinijohdannaiset
FI923968L (fi) Heterocykliskt substituerade kinolylmetoxifenylacetamider
MX9206710A (es) Derivados de piridinol
FI924145L (fi) 3-cykloalkylprop-2-enamidderivat